2UZN
Crystal structure of human CDK2 complexed with a thiazolidinone inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU RUH3R |
Temperature [K] | 100 |
Detector technology | IMAGE PLATE |
Collection date | 2003-12-30 |
Detector | RIGAKU (MSC) |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 53.591, 71.454, 72.284 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 15.000 - 2.300 |
R-factor | 0.206 |
Rwork | 0.199 |
R-free | 0.29700 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1b39 |
RMSD bond length | 0.018 |
RMSD bond angle | 1.863 |
Data reduction software | CrystalClear |
Data scaling software | d*TREK |
Phasing software | MOLREP |
Refinement software | REFMAC (5.2.0019) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 30.000 | 2.170 |
High resolution limit [Å] | 2.100 | 2.100 |
Rmerge | 0.170 | 0.500 |
Number of reflections | 16796 | |
<I/σ(I)> | 6.2 | 2.7 |
Completeness [%] | 99.5 | 96 |
Redundancy | 4.4 | 4.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 7 | VAPOR DIFFUSION HANGING DROP, ROOM TEMPERATURE, PEG3350, HEPES PH7.2, AMMONIUM ACETATE, pH 7.00 |